Showing results (31-40 of 259) with videos related to
Sort By:
Pageof 26
Journal of Immunological Methods|January 1, 1979
An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase AM B Pepys, C Tompkins, A D SmithThe Journal of Clinical Investigation|December 1, 1990
Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosisP N Hawkins, R Wootton, M B PepysMolecular Medicine (Cambridge, Mass.)|September 6, 2000
Human serum amyloid P component is a single uncomplexed pentamer in whole serumW L Hutchinson, E Hohenester, M B PepysThe American Journal of Pathology|March 1, 1992
Induction in mice of human light-chain-associated amyloidosisA Solomon, D T Weiss, M B PepysThe Journal of Investigative Dermatology|January 1, 1989
Tissue amyloid P component in normal human dermis is non-covalently associated with elastic fiber microfibrilsS M Breathnach, M B Pepys, H HintnerImmunology|June 1, 1978
Cell-mediated immunological responsiveness in mice decomplemented with cobra venom factorV M Rumjanek, L Brent, M B PepysStructure (London, England : 1993)|June 16, 1999
The physiological structure of human C-reactive protein and its complex with phosphocholineD Thompson, M B Pepys, S P WoodImmunology Letters|April 1, 1982
Enumeration of lymphocyte populations in whole peripheral blood of patients with antibody-mediated nephritis during treatment with cyclosporin AE O Pepys, A J Rees, M B PepysBiochimica Et Biophysica Acta|November 6, 1984
Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactoseC R Hind, P M Collins, M B PepysBritish Journal of Haematology|December 31, 1997
Amyloidosis: a review of recent diagnostic and therapeutic developmentsJ D Gillmore, P N Hawkins, M B PepysPageof 26